search
Back to results

Fruit and Vegetable Products Enriched With Fibre From Potato Starch With Prebiotic Properties for Children and Youth

Primary Purpose

Overweight and Obesity, Child Obesity, Hypertension

Status
Recruiting
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Vegetable and fruit mousse enriched with a fiber preparation from potato starch with prebiotic properties
Vegetable and fruit mousse
Dietary and physical activity counselling
Sponsored by
Children's Memorial Health Institute, Poland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overweight and Obesity focused on measuring child, prebiotics, obesity, overweight, treatment

Eligibility Criteria

6 Years - 10 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • overweight or obesity according to World Health Organization (WHO) definition
  • in 20 patients additionally to overweight or obesity also increase blood pressure
  • in 20 patients additionally to overweight or obesity also liver steatosis
  • willingness to participate

Exclusion Criteria:

  • allergy to mousse components
  • malabsorption syndrome
  • organ failure
  • food neophobia
  • other diseases or health problems which may interfere with study procedures or safety.

Sites / Locations

  • The Childen's Memorial Health InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention

Control

Arm Description

Mousse with prebiotic

Mousse without prebiotic

Outcomes

Primary Outcome Measures

BMI z-score change
Change in age and sex standardized BMI z-scores

Secondary Outcome Measures

Bioimpedance
Change in body composition on bioimpedance (fat-body-mass %)
Waist
Change in waist z-score (cm)
Gut microbiota
change in microbiome composition
Triglyceride
change in triglyceride-parameter of lipid metabolism (mg%)
Cholesterol
change in cholesterol-parameter of lipid metabolism (mg%)
Low-density lipoprotein (LDL)
change in Low-density lipoprotein (LDL)-parameter of lipid metabolism (mg%)
high-density lipoprotein (HDL)
change in high-density lipoprotein (HDL)-parameter of lipid metabolism (mg%)
very low-density lipoprotein (VLDL)
change in very low-density lipoprotein (VLDL)-parameter of lipid metabolism (mg%)
apolipoprotein
change in apolipoprotein-parameter of lipid metabolism (mg%)
uric acid
change in uric acid (mg%)
leptin
change in leptin (ng/mL)
adiponectin
change in adiponectin (ng/mL)
glucose, serum
change in glucose (mg%)
insulin, serum
change in insulin (mcIU/mL)
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), score, normal range<2,5
Glutathione (GSH)
change in Glutathione (GSH) (g Hgb/mcL)
glutathione peroxidase (GPx)
change in glutathione peroxidase (GPx) (mg/dL)
total antioxidant status (TAS)
change in total antioxidant status (TAS) (mcmol/L)
tumor necrosis factor α (TNF-alfa)
change in tumor necrosis factor α (TNF-alfa) (ng/mL)
interleukin 6 (IL-6)
change in interleukin 6 (IL-6) (ng/mL)
Monocyte Chemoattractant Protein-1 (MCP-1)
change in Monocyte Chemoattractant Protein-1 (MCP-1) (ng/mL)
Macrophage Inflammatory Protein-1 (MIP-1) alfa and beta
change in Macrophage Inflammatory Protein-1 (MIP-1) alfa and beta (ng/mL)
Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted (RANTES)
change in Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted (RANTES) (ng/mL)
lymphocyte T
change in lymphocyte T (%)

Full Information

First Posted
August 23, 2021
Last Updated
April 20, 2022
Sponsor
Children's Memorial Health Institute, Poland
Collaborators
Jan Dlugosz University in Czestochowa, Tymbark MWS Sp. with o.o. Sp. K., Poland, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Poland, Oncology Center-Institute of Maria Skłodowska - Curie, Poland
search

1. Study Identification

Unique Protocol Identification Number
NCT05140070
Brief Title
Fruit and Vegetable Products Enriched With Fibre From Potato Starch With Prebiotic Properties for Children and Youth
Official Title
Development and Implementation of an Innovative Technology for the Production New Generation Fruit and Vegetable Products Enriched With Dietary Fibre Preparation From Potato Starch With Prebiotic Properties for Children and Youth
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 6, 2021 (Actual)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
June 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Children's Memorial Health Institute, Poland
Collaborators
Jan Dlugosz University in Czestochowa, Tymbark MWS Sp. with o.o. Sp. K., Poland, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Poland, Oncology Center-Institute of Maria Skłodowska - Curie, Poland

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The main goal of the project is to test fruit and vegetable mousse, with the addition of a fiber preparation made of potato starch with prebiotic properties, on selected clinical, metabolic and immunological parameters in overweight and obese children. The study will be performed in a group of 80 to 100 children aged 6 to 10 years (pre-pubertal age), using a double-blind procedure. Children will be randomly assigned into two groups, i.e. the intervention group (they will receive a vegetable and fruit mousse with the addition of potato starch fiber preparation with prebiotic properties) and the control group (they will receive an identical preparation in their diet, but without the addition of potato starch fiber preparation).
Detailed Description
Purpose and nature of the study: The study financed by the National Center for Research and Development is aimed at examining the vegetable and fruit mousse with the addition of a potato starch fiber preparation with prebiotic properties, in terms of preventing overweight and obesity in children and limiting the occurrence of metabolic disorders secondary to obesity. Description of the procedures Children participating in the study will consume a daily fruit and vegetable mousse with or without the addition (control group) of a fiber-based potato starch preparation with prebiotic properties. Random selection will decide whether child will consume vegetable and fruit mousse with the addition of a fiber-based potato starch preparation with prebiotic properties. The study will be double blinded: neither parent and child, nor the attending physician will know whether the consumed mousse contains a fiber preparation. This method of conducting the study (random selection to the study group and control group and the so-called study blind) aims to eliminate the attitude of both the study participant and the observer to the therapy, which could affect the final assessment. Children will take the mousse every day for six months (6 months). In order to evaluate the effect of fruit and vegetable mousse with the addition of a fiber preparation made of potato starch with prebiotic properties, the following tests will be performed: measurements of height, weight and, based on this measurements body mass index (BMI) will be calculated, waist circumference and blood pressure, bioimpedance test to assess the content of adipose and muscle tissue in the body, ultrasound of the carotid vessels and the liver, the speed of the pulse wave using the oscillometric method, the elastographic examination with a fibroscan, the examination of the composition of the intestinal flora in a stool sample, and a venous blood sample (7-10 ml volume) will be taken to evaluate lipid, carbohydrate metabolism, liver function, adipose tissue function, antioxidant status, and immune response parameters. The mentioned tests will be performed three times during the observation, i.e. at the time of enrollment in the study, after 6 months of taking the fruit and vegetable mousse and 3 months after the end of the vegetable and fruit mousse. In connection with participation in the study, the Child and Parents will be provided with dietary and physical activity advice as well as psychologist's advice on the day of enrollment in the study and at 3-month intervals up to 9 months from the start of participation in the study. Additionally, 3 months after starting taking the fruit and vegetable mousse, anthropometric and blood pressure measurements will be performed. During the participation in the study possible side effects will be registered. A questionnaire containing questions about the child's date of birth, questions about the child's general health and taking medications, about the socio-demographic situation of the family, and food frequency questions will be completed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight and Obesity, Child Obesity, Hypertension, NAFLD
Keywords
child, prebiotics, obesity, overweight, treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomize, double blind, intervention vs control
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
the same appearance of the mousse (with and without active substance)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Mousse with prebiotic
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Mousse without prebiotic
Intervention Type
Dietary Supplement
Intervention Name(s)
Vegetable and fruit mousse enriched with a fiber preparation from potato starch with prebiotic properties
Intervention Description
All children in the intervention group will consume on daily basis vegetable and fruit mousse enriched with a fiber preparation from potato starch with prebiotic properties for six months
Intervention Type
Dietary Supplement
Intervention Name(s)
Vegetable and fruit mousse
Intervention Description
All children in the control group will consume on daily basis vegetable and fruit mousse for six months
Intervention Type
Behavioral
Intervention Name(s)
Dietary and physical activity counselling
Intervention Description
All children in the study will obtain 4 dietary and physical activity advice during the course of the study
Primary Outcome Measure Information:
Title
BMI z-score change
Description
Change in age and sex standardized BMI z-scores
Time Frame
6 to 9 months
Secondary Outcome Measure Information:
Title
Bioimpedance
Description
Change in body composition on bioimpedance (fat-body-mass %)
Time Frame
6 to 9 months
Title
Waist
Description
Change in waist z-score (cm)
Time Frame
6 to 9 months
Title
Gut microbiota
Description
change in microbiome composition
Time Frame
6 to 9 months
Title
Triglyceride
Description
change in triglyceride-parameter of lipid metabolism (mg%)
Time Frame
6 to 9 months
Title
Cholesterol
Description
change in cholesterol-parameter of lipid metabolism (mg%)
Time Frame
6 to 9 months
Title
Low-density lipoprotein (LDL)
Description
change in Low-density lipoprotein (LDL)-parameter of lipid metabolism (mg%)
Time Frame
6 to 9 months
Title
high-density lipoprotein (HDL)
Description
change in high-density lipoprotein (HDL)-parameter of lipid metabolism (mg%)
Time Frame
6 to 9 months
Title
very low-density lipoprotein (VLDL)
Description
change in very low-density lipoprotein (VLDL)-parameter of lipid metabolism (mg%)
Time Frame
6 to 9 months
Title
apolipoprotein
Description
change in apolipoprotein-parameter of lipid metabolism (mg%)
Time Frame
6 to 9 months
Title
uric acid
Description
change in uric acid (mg%)
Time Frame
6 to 9 months
Title
leptin
Description
change in leptin (ng/mL)
Time Frame
6 to 9 months
Title
adiponectin
Description
change in adiponectin (ng/mL)
Time Frame
6 to 9 months
Title
glucose, serum
Description
change in glucose (mg%)
Time Frame
6 to 9 months
Title
insulin, serum
Description
change in insulin (mcIU/mL)
Time Frame
6 to 9 months
Title
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
Description
change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), score, normal range<2,5
Time Frame
6 to 9 months
Title
Glutathione (GSH)
Description
change in Glutathione (GSH) (g Hgb/mcL)
Time Frame
6 to 9 months
Title
glutathione peroxidase (GPx)
Description
change in glutathione peroxidase (GPx) (mg/dL)
Time Frame
6 to 9 months
Title
total antioxidant status (TAS)
Description
change in total antioxidant status (TAS) (mcmol/L)
Time Frame
6 to 9 months
Title
tumor necrosis factor α (TNF-alfa)
Description
change in tumor necrosis factor α (TNF-alfa) (ng/mL)
Time Frame
6 months
Title
interleukin 6 (IL-6)
Description
change in interleukin 6 (IL-6) (ng/mL)
Time Frame
6 months
Title
Monocyte Chemoattractant Protein-1 (MCP-1)
Description
change in Monocyte Chemoattractant Protein-1 (MCP-1) (ng/mL)
Time Frame
6 months
Title
Macrophage Inflammatory Protein-1 (MIP-1) alfa and beta
Description
change in Macrophage Inflammatory Protein-1 (MIP-1) alfa and beta (ng/mL)
Time Frame
6 months
Title
Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted (RANTES)
Description
change in Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted (RANTES) (ng/mL)
Time Frame
6 months
Title
lymphocyte T
Description
change in lymphocyte T (%)
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: overweight or obesity according to World Health Organization (WHO) definition in 20 patients additionally to overweight or obesity also increase blood pressure in 20 patients additionally to overweight or obesity also liver steatosis willingness to participate Exclusion Criteria: allergy to mousse components malabsorption syndrome organ failure food neophobia other diseases or health problems which may interfere with study procedures or safety.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Piotr Socha, MD, PhD
Phone
+48 501065154
Email
p.socha@ipczd.pl
First Name & Middle Initial & Last Name or Official Title & Degree
Zbigniew Kułaga, MD, PhD
Phone
+48 603547517
Email
zakulaga@gmail.com
Facility Information:
Facility Name
The Childen's Memorial Health Institute
City
Warszawa
ZIP/Postal Code
03-984
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Piotr Socha, Professor, MD, PhD
Phone
+48 501 065 154
Email
zakulaga@gmail.com
First Name & Middle Initial & Last Name & Degree
Zbigniew Zbigniew, MD, PhD
Phone
603547517
Email
zakulaga@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie the results reported, after deidentification (text, tables, figures, and appendices).
IPD Sharing Time Frame
Immediately following publication. No end date.
IPD Sharing Access Criteria
Anyone who wishes to access the data
IPD Sharing URL
http://czd.pl
Citations:
PubMed Identifier
27155867
Citation
Barczynska R, Kapusniak J, Litwin M, Slizewska K, Szalecki M. Dextrins from Maize Starch as Substances Activating the Growth of Bacteroidetes and Actinobacteria Simultaneously Inhibiting the Growth of Firmicutes, Responsible for the Occurrence of Obesity. Plant Foods Hum Nutr. 2016 Jun;71(2):190-6. doi: 10.1007/s11130-016-0542-9.
Results Reference
result
PubMed Identifier
26373167
Citation
Barczynska R, Bandurska K, Slizewska K, Litwin M, Szalecki M, Libudzisz Z, Kapusniak J. Intestinal Microbiota, Obesity and Prebiotics. Pol J Microbiol. 2015;64(2):93-100.
Results Reference
result
PubMed Identifier
26929930
Citation
Barczynska R, Slizewska K, Litwin M, Szalecki M, Kapusniak J. Effects of dietary fiber preparations made from maize starch on the growth and activity of selected bacteria from the Firmicutes, Bacteroidetes, and Actinobacteria phyla in fecal samples from obese children. Acta Biochim Pol. 2016;63(2):261-6. doi: 10.18388/abp.2015_1068. Epub 2016 Feb 29.
Results Reference
result
PubMed Identifier
17679036
Citation
Litwin M, Sladowska J, Antoniewicz J, Niemirska A, Wierzbicka A, Daszkowska J, Wawer ZT, Janas R, Grenda R. Metabolic abnormalities, insulin resistance, and metabolic syndrome in children with primary hypertension. Am J Hypertens. 2007 Aug;20(8):875-82. doi: 10.1016/j.amjhyper.2007.03.005.
Results Reference
result
PubMed Identifier
23266543
Citation
Litwin M, Michalkiewicz J, Trojanek J, Niemirska A, Wierzbicka A, Szalecki M. Altered genes profile of renin-angiotensin system, immune system, and adipokines receptors in leukocytes of children with primary hypertension. Hypertension. 2013 Feb;61(2):431-6. doi: 10.1161/HYPERTENSIONAHA.111.00181. Epub 2012 Dec 24.
Results Reference
result
PubMed Identifier
27064274
Citation
Pinket AS, Van Lippevelde W, De Bourdeaudhuij I, Deforche B, Cardon G, Androutsos O, Koletzko B, Moreno LA, Socha P, Iotova V, Manios Y, De Craemer M; ToyBox-Study Group. Effect and Process Evaluation of a Cluster Randomized Control Trial on Water Intake and Beverage Consumption in Preschoolers from Six European Countries: The ToyBox-Study. PLoS One. 2016 Apr 11;11(4):e0152928. doi: 10.1371/journal.pone.0152928. eCollection 2016.
Results Reference
result
PubMed Identifier
21849603
Citation
Socha P, Grote V, Gruszfeld D, Janas R, Demmelmair H, Closa-Monasterolo R, Subias JE, Scaglioni S, Verduci E, Dain E, Langhendries JP, Perrin E, Koletzko B; European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. Am J Clin Nutr. 2011 Dec;94(6 Suppl):1776S-1784S. doi: 10.3945/ajcn.110.000596. Epub 2011 Aug 17.
Results Reference
result

Learn more about this trial

Fruit and Vegetable Products Enriched With Fibre From Potato Starch With Prebiotic Properties for Children and Youth

We'll reach out to this number within 24 hrs